View source for 6gfc


==Structure of the BTB/POZ domain of human 90K==
<StructureSection load='6gfc' size='340' side='right' caption='[[6gfc]], [[Resolution|resolution]] 3.30&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[6gfc]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Macmu Macmu]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6GFC OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6GFC FirstGlance]. <br>
</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6gfb|6gfb]]</td></tr>
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">LGALS3BP ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9544 MACMU])</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6gfc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6gfc OCA], [http://pdbe.org/6gfc PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6gfc RCSB], [http://www.ebi.ac.uk/pdbsum/6gfc PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6gfc ProSAT]</span></td></tr>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Cellular antiviral proteins interfere with distinct steps of replication cycles of viruses. The galectin 3 binding protein (LGALS3BP, also known as 90K) was previously shown to lower the infectivity of nascent HIV-1 virions when expressed in virus-producing cells. This antiviral effect was accompanied by impaired gp160Env processing and reduced viral incorporation of mature Env glycoproteins. Here, we examined the ability of 90K orthologs from primate species to reduce particle infectivity of distinct lentiviruses. We show that 90K's ability to diminish the infectivity of lentiviral particles is conserved within primate species, with the notable exception of 90K from rhesus macaque. Comparison of active and inactive 90K orthologs and variants uncovered that inhibition of processing of the HIV-1 Env precursor and reduction of cell surface expression of HIV-1 Env gp120 are required, but not sufficient for 90K-mediated antiviral activity. On the contrary, 90K-mediated reduction of virion-associated gp120 coincided with antiviral activity, suggesting that 90K impairs the incorporation of HIV-1 Env into budding virions. We show that a single "humanizing" amino acid exchange in the BTB (broad complex, tramtrack, and bric-a-brac)/POZ (poxvirus and zinc finger) domain is sufficient to fully rescue antiviral activity of a shortened version of rhesus macaque 90K, but not of the full-length protein. Comparison of the X-ray structures of the BTB/POZ domain of 90K from both species point towards a slightly larger hydrophobic patch at the surface of the rhesus macaque BTB domain that may modulate a direct interaction with either a second 90K domain or a different protein.IMPORTANCE The cellular 90K protein was shown to diminish the infectivity of nascent HIV-1 particles. When produced in 90K-expressing cells, particles bear lower amounts of the HIV-1 Env glycoprotein that is essential for attaching to and entering new target cells in the subsequent infection round. However, whether the antiviral function of 90K is conserved across primates is unknown. Here, we found that 90K orthologs from most primate species, but surprisingly not from rhesus macaques, inhibit HIV-1. Introduction of a single amino acid exchange in a short version of the rhesus macaque 90K protein, consisting of the two intermediate domains of 90K, resulted in full restoration of antiviral activity. Structural elucidation of the respective domain suggests that the absence of antiviral activity in the rhesus macaque factor may be linked to a subtle change in protein-protein interaction.

The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K is Species-Specific.,Lodermeyer V, Ssebyatika G, Passos V, Ponnurangam A, Malassa A, Ewald E, Sturzel CM, Kirchhoff F, Rotger M, Falk CS, Telenti A, Krey T, Goffinet C J Virol. 2018 May 9. pii: JVI.00226-18. doi: 10.1128/JVI.00226-18. PMID:29743357<ref>PMID:29743357</ref>

From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 6gfc" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Macmu]]
[[Category: Krey, T]]
[[Category: Ssebyatika, G]]
[[Category: Antiviral protein]]
[[Category: Btb/poz domain]]
[[Category: Hiv restriction factor]]